Skip to content

LAB - STANDARD BIOTOOLS INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchL

Standard Biotools Inc

LAB · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

L

LABStandard Biotools Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $1.72
52-wk low: $0.63
Prev close: $1.08
Mkt cap: $263.7M
Beta: 1.40
P/S: 3.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$71.6M

VG
Viking Global
Andreas Halvorsen · Q2 2026 13F
$48.3M
position
QR
Qube Research
Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings came in $0.02 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is profitable.

Net margin: 100.4%
Market cap: $264M

Valuation

P/S3.12
P/B0.48

Quality

Operating margin-38.9%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: LAB
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Market cap: $263.66M
Beta: 1.40

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.5x

Profit margin

+100.4%

Op margin

-38.9%

ROE

-11.2%

$4.0M

position

CW

Cathie Wood

Q4 2025 13F

$3.9M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for LAB

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.05-$0.02

-$0.03 expected

Next report

What the street expects next

EPS expected

-$0.02

-$0.02 to -$0.02

Revenue expected

$18.8M

1 analysts

Estimate drift

+0.02

Change in 30 days

-11.2%

ROA-6.6%

Growth

Beta1.40